UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057922
Receipt number R000066195
Scientific Title Examination of demand valve opening and closing conditions for efficient hydrogen inhalation using a nasal cannula
Date of disclosure of the study information 2025/05/20
Last modified on 2025/05/20 16:23:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of demand valve opening and closing conditions for efficient hydrogen inhalation using a nasal cannula

Acronym

Efficient hydrogen inhalation through a nasal cannula

Scientific Title

Examination of demand valve opening and closing conditions for efficient hydrogen inhalation using a nasal cannula

Scientific Title:Acronym

Efficient hydrogen inhalation through a nasal cannula

Region

Japan


Condition

Condition

Healthy volunteers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Although previous studies have reported on the safety and effectiveness of hydrogen inhalation, there is not enough clear evidence regarding the most efficient demand valve opening and closing sequence when inhaling hydrogen using a demand valve, or the amount of unabsorbed hydrogen discharged into the environment. This study will clarify the optimal demand valve opening and closing conditions to maximize the efficiency of hydrogen inhalation.

Basic objectives2

Others

Basic objectives -Others

This study will clarify the optimal demand valve opening and closing conditions to maximize the efficiency of hydrogen inhalation.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The subjects will be asked to breathe at a respiratory rate of 12 to 30, while blood oxygen saturation and the hydrogen concentration in the air around the nasal cavity and oral cavity will be measured, and the valve control conditions that enable efficient inhalation while minimizing hydrogen leakage will be explored.
Venous blood samples will be taken from some of the subjects to measure blood hydrogen concentrations.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

The study subjects will be asked to absorb approximately 2% hydrogen gas through a nasal cannula. A demand valve system will be used to supply hydrogen gas only when inhaling. The subjects will be asked to keep their breathing time constant by synchronizing it with a metronome. We will explore the demand valve opening and closing conditions that allow for the most efficient absorption of hydrogen.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Individuals who have received a sufficient explanation of this study and have given their voluntary written consent after fully understanding it.

Key exclusion criteria

People with underlying respiratory or circulatory diseases.
People with a history of hyperventilation syndrome.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Yamamoto

Organization

Yamaguchi University Graduate School of Medicine, Department of Health Sciences

Division name

Department of Clinical Labobatory Sciences

Zip code

755-8505

Address

1-1-1 Minamikogushi, Ube City, Yamaguchi Prefecture

TEL

0836-22-2834

Email

kenyama@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Yamamoto

Organization

Yamaguchi University Graduate School of Medicine, Department of Health Sciences

Division name

Department of Clinical Labobatory Sciences

Zip code

755-8505

Address

1-1-1 Minamikogushi, Ube City, Yamaguchi Prefecture

TEL

0834-22-2834

Homepage URL


Email

kenyama@yamaguychi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University

Institute

Department

Personal name



Funding Source

Organization

Yamaguchi University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamaguchi University Graduate School of Medicine, Department of Health Sciences, Life Science and Medical Research Ethics Committee

Address

1-1-1 Minamikogushi, Ube City, Yamaguchi Prefecture

Tel

0836-22-2007

Email

me202@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 05 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 05 Month 20 Day

Date of IRB


Anticipated trial start date

2025 Year 07 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 05 Month 20 Day

Last modified on

2025 Year 05 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066195